Objectives: Microsurgical denervation of the spermatic cord (MDSC) is a treatment option for chronic orchialgia (CO) refractory to conservative treatment. Studies showed specific nerve fibers as the possible cause of CO. We aimed to present the outcomes of ligation of these nerves using targeted MDSC. Methods: We retrospectively reviewed 30 cases who underwent targeted MDSC from August 2014 to February 2018. Patients included were under strict criteria. Pain was assessed preoperatively and postoperatively using a subjective visual analog scale (VAS) and objectively with the standardized and validated Pain Impact Questionnaire-6 (PIQ-6) score. Results: Data were available on 28 cases at repercussion. During a median follow-up of 12 months (range 10–29), 25 cases (89.2%) showed a significant reduction in pain and 3 (9.8%) had no change in pain by subjective VAS scoring. Of cases with a significant reduction in pain, 15 (53.5%) had complete resolution and 19 (67.9%) had a 50% or greater reduction. Objective PIQ-6 analysis showed a significant reduction in pain in 78.6% of patients at 6 months postoperatively, in 82.1% at 1 year, in 82.1% at 2 years. Conclusions: Targeted MDSC is an effective, minimally invasive approach with potential long-term durability in patients with refractory CO.

Keywords:
Microsurgery, Denervation of spermatic cord, Orchialgia
1.
Davis BE, Noble MJ, Weigel JW, Foret JD, Mebust WK. Analysis and management of chronic testicular pain.
J Urol
. 1990 May; 143(5): 936–9.
2.
Parekattil SJ, Gudeloglu A, Brahmbhatt JV, Priola KB, Vieweg J, Allan RW. Trifecta nerve complex: potential anatomical basis for microsurgical denervation of the spermatic cord for chronic orchialgia.
J Urol
. 2013 Jul; 190(1): 265–70.
3.
Morris C, Mishra K, Kirkman RJ. A study to assess the prevalence of chronic testicular pain in post-vasectomy men compared to non-vasectomised men.
J Fam Plann Reprod Health Care
. 2002 Jul; 28(3): 142–4.
4.
Nangia AK, Myles JL, Thomas AJ JR. Vasectomy reversal for the post-vasectomy pain syndrome: a clinical and histological evaluation.
J Urol
. 2000 Dec; 164(6): 1939–42.
5.
Massaron S, Bona S, Fumagalli U, Battafarano F, Elmore U, Rosati R. Analysis of post-surgical pain after inguinal hernia repair: a prospective study of 1,440 operations.
Hernia
. 2007 Dec; 11(6): 517–25.
6.
Edwards IS. Vasectomy reversal for treatment of the post-vasectomy pain syndrome.
J Urol
. 1997 Dec; 158(6): 2252.
7.
Devine CJ Jr, Schellhammer PF. The use of microsurgical denervation of the spermatic cord for orchialgia.
Trans Am Assoc Genitourin Surg
. 1978; 70: 149–51.
8.
Bhardwa JM, Kumar P, Nargund V. The aetiology, pathophysiology and management of chronic orchialgia.
BJU Int
. 2003 Sep; 92(4): 491.
9.
Strom KH, Levine LA. Microsurgical denervation of the spermatic cord for chronic orchialgia: long-term results from a single center.
J Urol
. 2008 Sep; 180(3): 949–53.
10.
Calixte N, Tojuola B, Kartal I, Gudeloglu A, Hirsch M, Etafy M, et al. Targeted Robotic Assisted Microsurgical Denervation of the Spermatic Cord for the Treatment of Chronic Orchialgia or Groin Pain: A Single Center, Large Series Review.
J Urol
. 2018 Apr; 199(4): 1015–1022.
11.
Tojuola B, Layman J, Kartal I, Gudelogul A, Brahmbhatt J, Parekattil S. Chronic -orchialgia: review of treatments old and new. 
Indian J Urol
. 2016 Jan-Mar; 32(1): 21–6.
12.
Tu XA, Gao Y, Zhang YD, Zhuang JT, Zhao JQ, Zhao LY, et al. Microsurgical denervation of the spermatic cord for treatment of idiopathic chronic orchialgia.
Chin Med J (Engl)
. 2012 Aug; 125(15): 2784–6.
13.
Strebel RT, Leippold T, Luginbuehl T, Muentener M, Praz V, Hauri D. Chronic scrotal pain syndrome: management among urologists in Switzerland.
Eur Urol
. 2005 Jun; 47(6): 812–6.
14.
Ciftci H, Savas M, Yeni E, Verit A, Topal U. Chronic orchialgia and associated diseases.
Curr Urol
. 2010; 4(2): 67–70.
15.
Gordhan CG, Sadeghi-Nejad H. Scrotal pain: evaluation and management.
Korean J Urol
. 2015 Jan; 56(1): 3–11.
16.
Costabile RA, Hahn M, McLeod DG. Chronic orchialgia in the pain prone patient: the clinical perspective.
J Urol
. 1991 Dec; 146(6): 1571–4.
17.
Kumar P, Mehta V, Nargund VH. Clinical management of chronic testicular pain.
Urol Int
. 2010; 84(2): 125–31.
18.
Quallich SA, Arslanian-Engoren C. Chronic testicular pain in adult men: an integrative literature review.
Am J Men Health
. 2013 Sep; 7(5): 402–13.
19.
Bolay H, Moskowitz MA. Mechanisms of pain modulation in chronic syndromes.
Neurology
. 2002 Sep; 59(5 Suppl 2):S2–7.
20.
Cassidy DJ. Early experience with microsurgical spermatic cord denervation for chronic orchialgia at a Canadian centre.
Can Urol Assoc J
. 2015 Jan-Feb; 9(1-2):e72–4.
21.
Levine L. Chronic orchialgia: evaluation and discussion of treatment options.
Ther Adv Urol
. 2010 Oct; 2(5-06): 209–14.
22.
Oka S, Shiraishi K, Matsuyama H. Microsurgical Anatomy of the Spermatic Cord and Spermatic Fascia: Distribution of Lymphatics, and Sensory and Autonomic Nerves.
J Urol
. 2016 Jun; 195(6): 1841–7.
23.
Yamamoto M, Hibi H, Katsuno S, Miyake K. Management of chronic orchialgia of unknown etiology.
Int J Urol
. 1995 Mar; 2(1): 47–9.
24.
Marconi M, Palma C, Troncoso P, Dell Oro A, Diemer T, Weidner W. Microsurgical spermatic cord denervation as a treatment for chronic scrotal content pain: a multicenter open label trial.
J Urol
. 2015 Nov; 194(5): 1323–7.
© 2019 S. Karger AG, Basel
2019
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.